Apiject Simplifying Drug Delivery with its Prefilled Injection Devices
Apiject uses a wide range of tools to support development and commercialization of our technology and it provides the benefits of a prefilled device at a lower cost than traditional pre-filled syringes, states Molly Weaver PhD, Chief Operating Officer and Paul Rutter, MD and Senior Vice President-Clinical Affairs, Apiject in their interaction with Aishwarya Saxena, Pharma Industrial India.
Prefilled Injection Devices | 02/01/2025
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy